Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer
Clinical trial NCT07310069 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07310069
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.